Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe.

Meek B, Ekström N, Kantsø B, Almond R, Findlow J, Gritzfeld JF, Sværke Jørgensen C, Ljungberg K, Atterfelt F, Batstra MR, Andeweg K, de Jong BAW, Prince HE, Lapé-Nixon M, Gageldonk PGM, Tcherniaeva I, Aaberge I, Herstad TK, Melin M, Rijkers GT, Berbers GA.

mSphere. 2019 Nov 27;4(6). pii: e00455-19. doi: 10.1128/mSphere.00455-19.

2.

Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density.

German EL, Solórzano C, Sunny S, Dunne F, Gritzfeld JF, Mitsi E, Nikolaou E, Hyder-Wright AD, Collins AM, Gordon SB, Ferreira DM.

Vaccine. 2019 Jul 9;37(30):3953-3956. doi: 10.1016/j.vaccine.2019.05.080. Epub 2019 Jun 5.

3.

Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017.

Adler H, Nikolaou E, Gould K, Hinds J, Collins AM, Connor V, Hales C, Hill H, Hyder-Wright AD, Zaidi SR, German EL, Gritzfeld JF, Mitsi E, Pojar S, Gordon SB, Roberts AP, Rylance J, Ferreira DM.

J Infect Dis. 2019 May 24;219(12):1989-1993. doi: 10.1093/infdis/jiz034.

4.

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Linley E, Bell A, Gritzfeld JF, Borrow R.

Vaccines (Basel). 2019 Jan 3;7(1). pii: E4. doi: 10.3390/vaccines7010004.

5.

Inflammation induced by influenza virus impairs human innate immune control of pneumococcus.

Jochems SP, Marcon F, Carniel BF, Holloway M, Mitsi E, Smith E, Gritzfeld JF, Solórzano C, Reiné J, Pojar S, Nikolaou E, German EL, Hyder-Wright A, Hill H, Hales C, de Steenhuijsen Piters WAA, Bogaert D, Adler H, Zaidi S, Connor V, Gordon SB, Rylance J, Nakaya HI, Ferreira DM.

Nat Immunol. 2018 Dec;19(12):1299-1308. doi: 10.1038/s41590-018-0231-y. Epub 2018 Oct 29.

6.

Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging.

German EL, Al-Hakim B, Mitsi E, Pennington SH, Gritzfeld JF, Hyder-Wright AD, Banyard A, Gordon SB, Collins AM, Ferreira DM.

Pneumonia (Nathan). 2018 Jun 5;10:5. doi: 10.1186/s41479-018-0048-3. eCollection 2018.

7.

Novel Analysis of Immune Cells from Nasal Microbiopsy Demonstrates Reliable, Reproducible Data for Immune Populations, and Superior Cytokine Detection Compared to Nasal Wash.

Jochems SP, Piddock K, Rylance J, Adler H, Carniel BF, Collins A, Gritzfeld JF, Hancock C, Hill H, Reiné J, Seddon A, Solórzano C, Sunny S, Trimble A, Wright AD, Zaidi S, Gordon SB, Ferreira DM.

PLoS One. 2017 Jan 20;12(1):e0169805. doi: 10.1371/journal.pone.0169805. eCollection 2017.

8.

Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.

Mitsi E, Roche AM, Reiné J, Zangari T, Owugha JT, Pennington SH, Gritzfeld JF, Wright AD, Collins AM, van Selm S, de Jonge MI, Gordon SB, Weiser JN, Ferreira DM.

Mucosal Immunol. 2017 Mar;10(2):385-394. doi: 10.1038/mi.2016.71. Epub 2016 Aug 31.

9.

Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.

Pennington SH, Pojar S, Mitsi E, Gritzfeld JF, Nikolaou E, Solórzano C, Owugha JT, Masood Q, Gordon MA, Wright AD, Collins AM, Miyaji EN, Gordon SB, Ferreira DM.

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1523-1531.

10.

Pneumococcal Colonization Rates in Patients Admitted to a United Kingdom Hospital with Lower Respiratory Tract Infection: a Prospective Case-Control Study.

Collins AM, Johnstone CM, Gritzfeld JF, Banyard A, Hancock CA, Wright AD, Macfarlane L, Ferreira DM, Gordon SB.

J Clin Microbiol. 2016 Apr;54(4):944-9. doi: 10.1128/JCM.02008-15. Epub 2016 Jan 20.

11.

First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial.

Collins AM, Wright AD, Mitsi E, Gritzfeld JF, Hancock CA, Pennington SH, Wang D, Morton B, Ferreira DM, Gordon SB.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):853-8. doi: 10.1164/rccm.201503-0542OC.

PMID:
26114410
12.

Genetic stability of pneumococcal isolates during 35 days of human experimental carriage.

Gladstone RA, Gritzfeld JF, Coupland P, Gordon SB, Bentley SD.

Vaccine. 2015 Jun 26;33(29):3342-5. doi: 10.1016/j.vaccine.2015.05.021. Epub 2015 May 23.

13.

Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage.

Glennie S, Gritzfeld JF, Pennington SH, Garner-Jones M, Coombes N, Hopkins MJ, Vadesilho CF, Miyaji EN, Wang D, Wright AD, Collins AM, Gordon SB, Ferreira DM.

Mucosal Immunol. 2016 Jan;9(1):56-67. doi: 10.1038/mi.2015.35. Epub 2015 Apr 29.

14.

The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition.

Cremers AJ, Zomer AL, Gritzfeld JF, Ferwerda G, van Hijum SA, Ferreira DM, Shak JR, Klugman KP, Boekhorst J, Timmerman HM, de Jonge MI, Gordon SB, Hermans PW.

Microbiome. 2014 Dec 15;2:44. doi: 10.1186/2049-2618-2-44. eCollection 2014.

15.

Density and duration of experimental human pneumococcal carriage.

Gritzfeld JF, Cremers AJ, Ferwerda G, Ferreira DM, Kadioglu A, Hermans PW, Gordon SB.

Clin Microbiol Infect. 2014 Dec;20(12):O1145-51. doi: 10.1111/1469-0691.12752. Epub 2014 Aug 11.

16.

Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.

Wall EC, Gritzfeld JF, Scarborough M, Ajdukiewicz KM, Mukaka M, Corless C, Lalloo DG, Gordon SB.

J Infect. 2014 Nov;69(5):440-6. doi: 10.1016/j.jinf.2014.06.011. Epub 2014 Jun 26.

17.

Impact of experimental human pneumococcal carriage on nasopharyngeal bacterial densities in healthy adults.

Shak JR, Cremers AJ, Gritzfeld JF, de Jonge MI, Hermans PW, Vidal JE, Klugman KP, Gordon SB.

PLoS One. 2014 Jun 10;9(6):e98829. doi: 10.1371/journal.pone.0098829. eCollection 2014.

18.

Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells.

Neill DR, Coward WR, Gritzfeld JF, Richards L, Garcia-Garcia FJ, Dotor J, Gordon SB, Kadioglu A.

Am J Respir Crit Care Med. 2014 May 15;189(10):1250-9. doi: 10.1164/rccm.201401-0128OC.

19.

Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.

Wright AK, Bangert M, Gritzfeld JF, Ferreira DM, Jambo KC, Wright AD, Collins AM, Gordon SB.

PLoS Pathog. 2013 Mar;9(3):e1003274. doi: 10.1371/journal.ppat.1003274. Epub 2013 Mar 28.

20.

Detection limits in pneumococcal carriage.

Gritzfeld JF, Gordon SB, Cremers A.

Pediatr Infect Dis J. 2013 Apr;32(4):425-6. doi: 10.1097/INF.0b013e31827add5f. No abstract available.

PMID:
23552682
21.

Experimental human pneumococcal carriage.

Gritzfeld JF, Wright AD, Collins AM, Pennington SH, Wright AK, Kadioglu A, Ferreira DM, Gordon SB.

J Vis Exp. 2013 Feb 15;(72). pii: 50115. doi: 10.3791/50115.

22.

Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults.

Ferreira DM, Neill DR, Bangert M, Gritzfeld JF, Green N, Wright AK, Pennington SH, Bricio-Moreno L, Moreno AT, Miyaji EN, Wright AD, Collins AM, Goldblatt D, Kadioglu A, Gordon SB.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):855-64. doi: 10.1164/rccm.201212-2277OC. Erratum in: Am J Respir Crit Care Med. 2013 May 15;187(10):1153. Bricio Moreno, Laura [corrected to Bricio-Moreno, Laura].

23.

Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.

Wright AK, Ferreira DM, Gritzfeld JF, Wright AD, Armitage K, Jambo KC, Bate E, El Batrawy S, Collins A, Gordon SB.

PLoS Pathog. 2012;8(4):e1002622. doi: 10.1371/journal.ppat.1002622. Epub 2012 Apr 5.

24.

Comparison between nasopharyngeal swab and nasal wash, using culture and PCR, in the detection of potential respiratory pathogens.

Gritzfeld JF, Roberts P, Roche L, El Batrawy S, Gordon SB.

BMC Res Notes. 2011 Apr 13;4:122. doi: 10.1186/1756-0500-4-122.

Supplemental Content

Loading ...
Support Center